- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07657910
Evaluation of Occlusal Contact Distribution in Digitally Fabricated Implant-Retained Fixed Partial Dentures in Mandibular Kennedy Class II Patients Following Artificial Intelligence Bite Optimization: A Quasi-Experimental Study (Quasi)
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Noha Walid Barakat, Masters degree
- Numéro de téléphone: 002 +201149902334
- E-mail: noha.barakat@dentistry.cu.edu.eg
Sauvegarde des contacts de l'étude
- Nom: Ahmed Mustafa Kotb, Lecturer
- Numéro de téléphone: 002 01006697790
- E-mail: ahmed.kotb@dentistry.cu.edu.eg
Lieux d'étude
-
-
-
Giza, Egypte, 12511
- Faculty of Dentistry - Cairo University
-
Contact:
- Noha Barakat, Masters degree
- Numéro de téléphone: 002 01149902334
- E-mail: noha.barakat@dentistry.cu.edu.eg
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients with a unilateral mandibular distal extension area (Kennedy Class II partially edentulous mandibular arch) and who are indicated for the insertion of 2 implants.
- Fully dentate opposing maxillary arch or restored with a suitable, well constructed fixed prosthesis.
- The remaining teeth should be in good periodontal health, with no signs of inflammation or movement.
- The edentulous area should be covered by a healthy, firm mucoperiosteum, with no or minimal tissue undercut.
- Patient should be with class I occlusion.
- No occlusal disorder; stable jaw relation.
- No TMD signs or symptoms.
- Patients should be in generally good health and free of systemic conditions that can affect the implant treatment, such as diabetes mellitus.
Exclusion Criteria:
- Patients with psychological or mental disorders.
- Patients with insufficient interarch space.
- Patients with parafunctional habits, such as bruxism.
- After the healing phase and exactly before the prosthetic phase, if the inserted implants showed any signs of peri-implantitis or aggressive crestal bone resorption, then this case will be excluded and replaced with another case.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Non randomisé
- Modèle interventionnel: Affectation séquentielle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Before
The recruited patients will be screened for proper bone architecture and CBCTs will be taken for proper virtual implant planning.
Two implants will be placed in the edentulous span in all participants.
All surgical steps will be held according to standard protocol.
After the implant osseointegration period, the prosthetic phase will start with implant exposure and placement of multiunit abutments.
After gingival healing, intraoral scans for the implants timing using abutment level scan bodies will be taken.
Then, the fabrication of implant-retained fixed partial denture will be done with a fully digital workflow.
|
The recruited patients will be screened for proper bone architecture and CBCTs will be taken for proper virtual implant planning.
Two implants will be placed in the edentulous span in all participants.
All surgical steps will be held according to standard protocol.
After the implant osseointegration period, the prosthetic phase will start with implant exposure and placement of multiunit abutments.
After gingival healing, intraoral scans for the implants timing using abutment level scan bodies will be taken.
Then, the fabrication of implant-retained fixed partial denture will be done with a fully digital workflow.
|
|
Comparateur actif: After
The data acquisition will take place by scanning the patients using Medit intraoral scanner.
Then, the scanned stls will be imported in 3shape software version 2024 and bite optimization module in it will be run.
It automatically recalculates the position of the bite relation using its integrated AI.
After that, the resulted STLs will be exported and re-imported to ExoCAD software to design the prostheses.
|
The data acquisition will take place by scanning the patients using Medit intraoral scanner.
Then, the scanned stls will be imported in 3shape software version 2024 and bite optimization module in it will be run.
It automatically recalculates the position of the bite relation using its integrated AI.
After that, the resulted STLs will be exported and re-imported to ExoCAD software to design the prostheses.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Occlusal contact distribution
Délai: From enrollment till the end of the study 17 weeks
|
The 1ry outcome will be assessed on the day of the prosthesis delivery. First, the reading of the occlusal contact distribution will be taken by using the T-scan device before seating the prosthesis intraorally. Then, the retained fixed prosthesis will be seated on the implant abutment, and the prosthetic screw will be screwed to the optimum torque. Another reading of the occlusal contact distribution will be taken by using the T-scan device after seating and torquing the prosthesis intraorally. Finally, the screw access channels will be closed by flowable resin composite material. |
From enrollment till the end of the study 17 weeks
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 24226
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .